PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS

PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS

An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Baba, Hiroko, Yasuda, Nobuyuki, Mori, Masahiko, Tago, Fumitoshi, Nakano, Tomohisa
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Baba, Hiroko
Yasuda, Nobuyuki
Mori, Masahiko
Tago, Fumitoshi
Nakano, Tomohisa
description An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis. The pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient and is used such that at least 100 mg per dose of the anti-fractalkine antibody is subcutaneously administered to a human in need thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3159007A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3159007A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3159007A13</originalsourceid><addsrcrecordid>eNrjZLAJ8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw8w9SCAlydQzx9HNXCPJwDfV1DPH3dFFwDArxCAIqCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcaGppYGBuaOhsZEKAEA7aQppQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS</title><source>esp@cenet</source><creator>Baba, Hiroko ; Yasuda, Nobuyuki ; Mori, Masahiko ; Tago, Fumitoshi ; Nakano, Tomohisa</creator><creatorcontrib>Baba, Hiroko ; Yasuda, Nobuyuki ; Mori, Masahiko ; Tago, Fumitoshi ; Nakano, Tomohisa</creatorcontrib><description>An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis. The pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient and is used such that at least 100 mg per dose of the anti-fractalkine antibody is subcutaneously administered to a human in need thereof.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170426&amp;DB=EPODOC&amp;CC=EP&amp;NR=3159007A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170426&amp;DB=EPODOC&amp;CC=EP&amp;NR=3159007A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Baba, Hiroko</creatorcontrib><creatorcontrib>Yasuda, Nobuyuki</creatorcontrib><creatorcontrib>Mori, Masahiko</creatorcontrib><creatorcontrib>Tago, Fumitoshi</creatorcontrib><creatorcontrib>Nakano, Tomohisa</creatorcontrib><title>PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS</title><description>An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis. The pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient and is used such that at least 100 mg per dose of the anti-fractalkine antibody is subcutaneously administered to a human in need thereof.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAJ8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw8w9SCAlydQzx9HNXCPJwDfV1DPH3dFFwDArxCAIqCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcaGppYGBuaOhsZEKAEA7aQppQ</recordid><startdate>20170426</startdate><enddate>20170426</enddate><creator>Baba, Hiroko</creator><creator>Yasuda, Nobuyuki</creator><creator>Mori, Masahiko</creator><creator>Tago, Fumitoshi</creator><creator>Nakano, Tomohisa</creator><scope>EVB</scope></search><sort><creationdate>20170426</creationdate><title>PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS</title><author>Baba, Hiroko ; Yasuda, Nobuyuki ; Mori, Masahiko ; Tago, Fumitoshi ; Nakano, Tomohisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3159007A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Baba, Hiroko</creatorcontrib><creatorcontrib>Yasuda, Nobuyuki</creatorcontrib><creatorcontrib>Mori, Masahiko</creatorcontrib><creatorcontrib>Tago, Fumitoshi</creatorcontrib><creatorcontrib>Nakano, Tomohisa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Baba, Hiroko</au><au>Yasuda, Nobuyuki</au><au>Mori, Masahiko</au><au>Tago, Fumitoshi</au><au>Nakano, Tomohisa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS</title><date>2017-04-26</date><risdate>2017</risdate><abstract>An object of the present invention is to provide a pharmaceutical composition comprising an anti-fractalkine antibody, wherein the pharmaceutical composition brings about therapeutically effective amelioration in rheumatoid arthritis after administration to a human subject. The present invention provides a pharmaceutical composition for the treatment of rheumatoid arthritis. The pharmaceutical composition comprises an anti-fractalkine antibody and a pharmaceutically acceptable excipient and is used such that at least 100 mg per dose of the anti-fractalkine antibody is subcutaneously administered to a human in need thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3159007A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A44%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Baba,%20Hiroko&rft.date=2017-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3159007A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true